IOSP on Nasdaq

Innospec

Specialty chemical company

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units: The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

1999Founded1

Compare with Ingevity Corp, BALCHEM CORP or FMC Corporation, or pick any stock.

  • TickerIOSP on Nasdaq1
  • Industrypetroleum1
  • HeadquartersUnited States1
  • Websitewww.innospecinc.com
  • Incorporated inDE5
  • Business address8310 South Valley Highway, Suite 350, Englewood, Co 801125
  • Filer categoryLarge accelerated filer5
  • Legal formCorporation4
  • LEI213800SQBACNY5IWJO684
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 28515324

See how the biggest companies compare on our leaderboards

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

27.7%Gross margin7
7.3%Operating margin7
6.6%Net margin7
-3.7%Revenue growth, 20257
8.8%Return on equity7

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Fuel Specialties brought in 39% of the revenue Innospec broke down this way in fiscal 2025.

  1. Fuel Specialties$701.5M739%up 0% from 2024
  2. Performance Chemicals$681.4M738%up 4% from 2024
  3. Oilfield Services$395.1M722%down 19% from 2024
Business segments by year
Business segments202320242025
Fuel Specialties$695.9M$701.1M$701.5M
Performance Chemicals$561.6M$653.7M$681.4M
Oilfield Services$691.3M$490.6M$395.1M

Regions

United States brought in 45% of the revenue Innospec broke down this way in fiscal 2025.

  1. United States$951.7M745%down 8% from 2024
  2. United Kingdom$793.2M737%down 4% from 2024
  3. Rest Of World$379.0M718%up 31% from 2024
Regions by year
Regions202320242025
United States$1.2B$1.0B$951.7M
United Kingdom$857.7M$823.4M$793.2M
Rest Of World$199.4M$288.9M$379.0M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue72¢$1.3B
  • Research and development3¢$51.0M
  • Selling, general and admin16¢$285.1M
  • Other costs1¢$18.2M
  • Income tax1¢$21.5M
  • Profit7¢$116.6M

Out of $1.8B in revenue.7

Where each dollar of operating cash went, fiscal 2025

  • Dividends paid31¢$42.4M
  • Share buybacks17¢$23.9M
  • Kept or used elsewhere52¢$72.0M

Out of $138.3M of cash from operations.7

Financial statements

Revenue8910117$1.8B in 2025+17% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $1.5B$1.5B20192020: $1.2B$1.2B2020−21%2021: $1.5B$1.5B2021+24%2022: $2.0B$2.0B2022+32%2023: $1.9B$1.9B2023−1%2024: $1.8B$1.8B2024−5%2025: $1.8B$1.8B2025−4%
Gross profit8910117$492.4M in 2025+6% since 2019
0$200.0M$400.0M$600.0M2019: $466.2M$466.2M20192020: $342.7M$342.7M2020−26%2021: $434.9M$434.9M2021+27%2022: $586.7M$586.7M2022+35%2023: $591.1M$591.1M2023+1%2024: $542.9M$542.9M2024−8%2025: $492.4M$492.4M2025−9%
Operating income8910117$129.5M in 2025−14% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $149.9M$149.9M20192020: $33.7M$33.7M2020−78%2021: $132.1M$132.1M2021+292%2022: $187.3M$187.3M2022+42%2023: $161.6M$161.6M2023−14%2024: $177.9M$177.9M2024+10%2025: $129.5M$129.5M2025−27%
Net income8910117$116.6M in 2025+4% since 2019
0$50.0M$100.0M$150.0M2019: $112.2M$112.2M20192020: $28.7M$28.7M2020−74%2021: $93.1M$93.1M2021+224%2022: $133.0M$133.0M2022+43%2023: $139.1M$139.1M2023+5%2024: $35.6M$35.6M2024−74%2025: $116.6M$116.6M2025+228%

Every line of the income statement as filed: the last 3 fiscal years, latest first.7

Period ending2025-12-312024-12-312023-12-31
Net sales$1.8B$1.8B$1.9B
Cost of goods sold-$1.3B-$1.3B-$1.4B
Gross profit$492.4M$542.9M$591.1M
Selling, general and administrative-$285.1M-$305.3M-$380.5M
Research and development-$51.0M-$56.5M-$49.0M
Adjustment to fair value of contingent consideration$15.9M-$3.4M$0
Restructuring charge-$900.0K$0$0
Impairment of property, plant and equipment-$22.9M$0$0
Impairment of intangible assets-$19.1M$0$0
Profit on disposal of property, plant and equipment$200.0K$200.0K$0
Total operating expenses-$362.9M-$365.0M-$429.5M
Operating income$129.5M$177.9M$161.6M
Other income/(expense), net-$600.0K$9.6M$10.5M
Pension scheme settlement charge$0-$155.6M$0
Interest income/(expense), net$9.2M$9.3M$2.3M
Income before income tax expense$138.1M$41.2M$174.4M
Income tax expense-$21.5M-$5.6M-$35.3M
Net income$116.6M$35.6M$139.1M
Basic$4.69$1.43$5.60
Diluted$4.67$1.42$5.56
Basic24.9M shares24.9M shares24.9M shares
Diluted25.0M shares25.1M shares25.0M shares

Compare Innospec with another company

Leadership

Who has led Innospec, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Patrick Williams2014–now

President

  1. Patrick Williams2015–now

Chief financial officer

  1. Ian Cleminson2006–now
200020052010201520202025
Board members and other officers (31)

Products and brands

  • specialty chemicals

Listed on Wikidata.1

Locations

Innospec is headquartered in Englewood, Colorado, and has major regional centers in the United Kingdom and Singapore, along with international offices and processing facilities.

Production plants are located in multiple countries including UK, France, Germany, Philippines, the United States, Italy and Spain.

The company has around 2,000 employees located in 20 countries.

Products

Innospec markets detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, antioxidants, cetane improvers, TEL, and a range of other chemicals as fuel additives.

Read the full text

The Oilfield Services division provides products and services for drilling, fracturing & stimulation and production operations to the oil and gas industry

In Personal Care, the company makes a range of surfactants, emollients and silicone formulations.

From Wikipedia’s article on Innospec, shared under CC BY-SA 4.0.6

Acquisitions

Innospec has made the following recent acquisitions and divestments:

Strata Control was acquired in December 2013 in Oilfield Drilling Specialties.

Chemsil Silicones and Chemtec were acquired in September 2013 in Personal Care.

Bachman Services was acquired in November 2013 in Oilfield Production Specialties.

Read the full text

Independence Oilfield Chemicals was acquired in November 2014 in Oilfield Chemicals.

Innospec divested its Aroma Chemicals business to Emerald Kalama in July 2015.

As of January 1, 2016; Bachman, Strata and Independence Oilfield Chemicals have been reorganized into one company, Innospec Oilfield Specialties.

On January 3, 2017, Innospec announced it had completed the acquisition of the European Differentiated Surfactants business from Huntsman

From Wikipedia’s article on Innospec, shared under CC BY-SA 4.0.6

Former names

  • OCTEL CORPJun 9, 1998 to Jan 9, 20065

Timeline

  1. Feb 18, 2014New chief executive Patrick Williams becomes CEO15
  2. 1999Founded Founded1

Filings

281 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 34 major events, 179 insider forms, 29 large holders, 19 other. The latest 20:

  1. Oct 7, 2026SCHEDULE 13G/A EDGAR
  2. Oct 7, 2026SCHEDULE 13G EDGAR
  3. Oct 5, 20264 EDGAR
  4. Oct 5, 20264 EDGAR
  5. Oct 5, 20264 EDGAR
  6. Oct 5, 20264 EDGAR
  7. Oct 5, 20264 EDGAR
  8. Oct 5, 20264 EDGAR
  9. Aug 5, 202610-Q EDGAR
  10. Aug 5, 20268-K EDGAR
  11. Jul 31, 2026SCHEDULE 13G/A EDGAR
  12. Jul 14, 2026SCHEDULE 13G EDGAR
  13. Jul 1, 20263 EDGAR
  14. Jun 4, 20268-K EDGAR
  15. May 29, 2026SD EDGAR
  16. May 13, 20268-K EDGAR
  17. May 8, 202610-Q EDGAR
  18. May 8, 20268-K EDGAR
  19. Apr 30, 2026SCHEDULE 13G EDGAR
  20. Apr 29, 2026SCHEDULE 13G EDGAR

The 281 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

67 open-market trades by officers, directors and large owners since October 2021: 10 buys and 57 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 3, 2026Jones David B.SVP, GC & CCOSale1,028$75.64$77.8KForm 4
Feb 27, 2026Blackmore Milton CDirectorSale594$76.55$45.5KForm 4
Feb 27, 2026PADFIELD LarryDirectorSale594$76.55$45.5KForm 4
Feb 27, 2026Poccia ClaudiaDirectorSale119$76.56$9.1KForm 4
Feb 27, 2026LANDLESS DAVIDDirectorSale594$76.55$45.5KForm 4
Feb 27, 2026Cleminson IanEVP & CFOSale2,380$76.55$182.2KForm 4
Feb 27, 2026Blackmore Milton CDirectorSale594$76.56$45.5KForm 4
Feb 27, 2026PADFIELD LarryDirectorSale594$76.56$45.5KForm 4
Feb 27, 2026Poccia ClaudiaDirectorSale119$76.56$9.1KForm 4
Feb 27, 2026LANDLESS DAVIDDirectorSale594$76.56$45.5KForm 4
Feb 27, 2026Cleminson IanEVP & CFOSale2,380$76.56$182.2KForm 4
Feb 20, 2026Blackmore Milton CDirectorSale1,030$81.84$84.3KForm 4
Feb 20, 2026PADFIELD LarryDirectorSale1,030$81.84$84.3KForm 4
Nov 14, 2025PARRETTE LESLIE JDirectorBuy340$74.09$25.2KForm 4
May 13, 2025PARRETTE LESLIE JDirectorSale446$90.63$40.4KForm 4
Mar 3, 2025Cleminson IanEVP & CFOSale4,275$100.98$431.7KForm 4
Feb 24, 2025BARNES CORBINSVP, Corporate Dev and IRSale598$103.06$61.6KForm 4
Feb 21, 2025PADFIELD LarryDirectorSale196$103.30$20.2KForm 4
Feb 21, 2025BOON PHILIP JOHNExecutive VP Business OpsSale3,754$103.30$387.8KForm 4
Feb 21, 2025BARNES CORBINSVP, Corporate Dev and IRSale2,692$103.30$278.1KForm 4

All 67 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.4,381,323$356.6M0.0%+502,348
Allspring Global Investments Holdings, LLC1,892,471$154.7M0.2%−423,471
Vanguard Portfolio Management LLC1,884,244$153.4M0.0%+24,153
Dimensional Fund Advisors LP1,305,038$106.2M0.0%+62,949
Vanguard Capital Management LLC1,108,107$90.2M0.0%−6,491
State Street Corp996,027$81.1M0.0%+31,692
Nuveen, LLC755,723$61.5M0.0%+112,475
Geode Capital Management, LLC666,589$54.3M0.0%+35,997
Goldman Sachs Group Inc662,210$53.9M0.0%+170,199
Victory Capital Management Inc660,110$53.7M0.0%−204,884
Two Sigma Investments, LP568,709$46.3M0.0%−24,330
Assenagon Asset Management S.A.545,564$44.4M0.0%+54,680
Aqr Capital Management LLC482,545$39.3M0.0%+170,480
Brown Advisory Inc408,468$33.2M0.1%+112,003
Jpmorgan Chase & Co370,574$30.0M0.0%−55,476
Charles Schwab Investment Management Inc355,658$28.9M0.0%−10,216
Gendell Jeffrey L324,504$26.4M0.2%+30,000
Royce & Associates LP308,726$25.1M0.2%+47,390
Northern Trust Corp303,044$24.7M0.0%+18,805
Qube Research & Technologies Ltd285,849$23.3M0.0%−120,775
Western Standard LLC236,833$19.3M6.5%+10,000
Bank Of America Corp /de/235,742$19.2M0.0%−55,024
Morgan Stanley230,793$18.8M0.0%−4,778
Renaissance Technologies LLC185,000$15.1M0.0%+66,100
Panagora Asset Management Inc182,538$14.9M0.0%+62,863

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56